USANA Health Sciences, Inc.

USNA Consumer Defensive Packaged Foods

USANA Health Sciences, Inc.’s revenue for fiscal 2025 (year ended December 2025) was $925.3 million, up 8.28% from fiscal 2024. In the quarter to June 2026, revenue fell 5.33%, EPS fell 323.1% and free cash flow grew 180.6%, each against the same quarter a year earlier.

15.54 0.16 +1.04%
Market cap
$284.2M
P/E
0.0×
Fwd P/E
14.0×
Dividend yield
—
F-score
7/9
Altman Z
3.59
Beneish M
n/a
Dividend safety
70/100
Jun '26 Mar '26 Dec '25 Sep '25 Older periods
Piotroski F-Score
5 6 7 5

+8 more TTM periods

ROE
(4.19%) 1.65% 2.02% 3.20%
ROA
(3.08%) 1.19% 1.44% 2.43%
ROIC
(0.19%) 5.85% 6.24% 6.83%
Return on Tangible Assets
(8.22%) 3.27% 4.23% 7.03%
Average Days of Receivables
1.33 3.81 1.69 0.00
Free Cash Flow per Share
1.08 0.38 0.67 1.02
Free Cash Flow
19.90 6.91 12.43 18.69
Other line items

Show all line items

Columns are period end dates